Literature DB >> 32623708

[Caregiver burden in patients with Parkinson's disease].

Gerhard Ransmayr.   

Abstract

Parkinson patients suffering from disease progression become increasingly dependent on personal care, which is mostly provided by female family members. Burden of care correlates with severity of motor impairment, neurocognitive and neuropsychiatric symptoms, behavioral abnormalities, autonomic nervous system disorders, impairment of micturition, sleep, and dependence. Caregiver burden also results from restrictions in time for personal matters, family, leisure and social activities, occupational limits, costs, lack of social support and impairment of sleep, depression, and emotional and other health problems of the carer (such as depression and anxiety). Caregivers at risk of caregiver burden need to be identified in time in order to provide information and adequate personal, psychological and financial support. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2020        PMID: 32623708     DOI: 10.1055/a-1120-8567

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  3 in total

Review 1.  Challenges of caregiving to neurological patients.

Authors:  Gerhard Ransmayr
Journal:  Wien Med Wochenschr       Date:  2021-05-05

2.  Divergence Between Informant and Self-Ratings of Activities of Daily Living Impairments in Parkinson's Disease.

Authors:  Sara Becker; Susanne Solbrig; Katja Michaelis; Bettina Faust; Kathrin Brockmann; Inga Liepelt-Scarfone
Journal:  Front Aging Neurosci       Date:  2022-02-11       Impact factor: 5.750

3.  Caregiver burden in patients with behavioural variant frontotemporal dementia and non-fluent variant and semantic variant primary progressive aphasia.

Authors:  Michael Guger; Stefan Raschbacher; Lukas Kellermair; Milan R Vosko; Christian Eggers; Thomas Forstner; Karin Leitner; Alexandra Fuchs; Franz Fellner; Gerhard Ransmayr
Journal:  J Neural Transm (Vienna)       Date:  2021-07-19       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.